SAFC Hitech, a focus area of SAFC and part of the Sigma-Aldrich Corporation, today announced that it will be participating in a webcast, along with representatives from Aviza Technology and ST Microelectronics, to discuss the subject of Atomic Layer Deposition.
NanoBio Corporation, a biopharmaceutical company focused on developing and commercializing novel products for the prevention and treatment of infectious diseases, today announced the addition of Joyce Sutcliffe, Ph.D., as vice president of research.
IDGLOBAL's latest generation of Nano-Molecular Markers and Track n Trace nanotechnologies can be applied to virtually any product in nano trace amounts, in selected areas and can only be detected by highly sensitive handheld analyzers that are portable and can provide 100% item verification, in the field, in real time in a matter of seconds.
SEMATECH engineers have made significant advances in moving forward the infrastructure that will prepare extreme ultraviolet lithography (EUVL) for cost-effective manufacturing, according to papers being presented at the 2007 International EUVL Symposium.
CVD Equipment Corporation announced today that Leonard Rosenbaum, President and CEO will present at the Global Crown Capital Second Annual Nanotechnology Investment Conference in San Francisco on November 7 at 1:30 PM.
Industrial Nanotech announced today that new guidelines issued recently by the Dubai government will require all new construction in Dubai to comply with state-mandated standards for energy and environmental efficiency beginning in January 2008.
The new NanoPearl cover family is equipped with a filler system that is unique in particle size distribution and homogeneity. The average particle size measures only 10-20 nm which is a breakthrough in an industrial application.
PI (Physik Instrumente) L.P. - a leading manufacturer of ultra-precision motion-control and sensing equipment for bionanotechnology, photonics, semiconductor and life science applications - offers a new brochure on piezo ceramic linear motors.
Celator Pharmaceuticals today announced positive results from preclinical studies to evaluate the optimal ratio of irinotecan and cisplatin to deliver synergistic benefit against a range of tumor cell lines in vitro.